These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23990137)

  • 1. Pneumocystis jirovecii (Pj) quantitative PCR to differentiate Pj pneumonia from Pj colonization in immunocompromised patients.
    Maillet M; Maubon D; Brion JP; François P; Molina L; Stahl JP; Epaulard O; Bosseray A; Pavese P
    Eur J Clin Microbiol Infect Dis; 2014 Mar; 33(3):331-6. PubMed ID: 23990137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined quantification of pulmonary Pneumocystis jirovecii DNA and serum (1->3)-β-D-glucan for differential diagnosis of pneumocystis pneumonia and Pneumocystis colonization.
    Damiani C; Le Gal S; Da Costa C; Virmaux M; Nevez G; Totet A
    J Clin Microbiol; 2013 Oct; 51(10):3380-8. PubMed ID: 23903553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative real-time PCR and the (1→3)-β-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization.
    Matsumura Y; Ito Y; Iinuma Y; Yasuma K; Yamamoto M; Matsushima A; Nagao M; Takakura S; Ichiyama S
    Clin Microbiol Infect; 2012 Jun; 18(6):591-7. PubMed ID: 21973089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of HIV Infection Status on Interpretation of Quantitative PCR for Detection of Pneumocystis jirovecii.
    Louis M; Guitard J; Jodar M; Ancelle T; Magne D; Lascols O; Hennequin C
    J Clin Microbiol; 2015 Dec; 53(12):3870-5. PubMed ID: 26468505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients.
    Alanio A; Desoubeaux G; Sarfati C; Hamane S; Bergeron A; Azoulay E; Molina JM; Derouin F; Menotti J
    Clin Microbiol Infect; 2011 Oct; 17(10):1531-7. PubMed ID: 20946413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pneumocystis jirovecii and quantitative PCR: Pneumonia or colonization?].
    Gazaignes S; Bergeron A; Menotti J; Desseaux K; Molina JM; De Castro N
    Rev Mal Respir; 2020 Apr; 37(4):299-307. PubMed ID: 32273116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of 2 real-time PCR assays for diagnosis of Pneumocystis jirovecii pneumonia in human immunodeficiency virus (HIV) and non-HIV immunocompromised patients.
    Montesinos I; Brancart F; Schepers K; Jacobs F; Denis O; Delforge ML
    Diagn Microbiol Infect Dis; 2015 Jun; 82(2):143-7. PubMed ID: 25801778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Pneumocystis jirovecii by Quantitative PCR To Differentiate Colonization and Pneumonia in Immunocompromised HIV-Positive and HIV-Negative Patients.
    Fauchier T; Hasseine L; Gari-Toussaint M; Casanova V; Marty PM; Pomares C
    J Clin Microbiol; 2016 Jun; 54(6):1487-1495. PubMed ID: 27008872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum (1 → 3) β-D-glucan assay for discrimination between Pneumocystis jirovecii pneumonia and colonization.
    Tasaka S; Kobayashi S; Yagi K; Asami T; Namkoong H; Yamasawa W; Ishii M; Hasegawa N; Betsuyaku T
    J Infect Chemother; 2014 Nov; 20(11):678-81. PubMed ID: 25066434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of a real-time PCR for diagnosis of Pneumocystis pneumonia in immunocompromised patients - Experience from a tertiary care center, India.
    S D; S TD; Gupta R; Varughese S; Varghese GM; George B; Michael JS
    J Mycol Med; 2022 May; 32(2):101241. PubMed ID: 34999296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the performance of DiaSorin molecular Pneumocystis jirovecii-CMV multiplex real-time PCR assay from bronchoalveolar lavage samples.
    Kilic A; Elliott S; Hester L; Palavecino E
    J Mycol Med; 2020 Jun; 30(2):100936. PubMed ID: 32044156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ability of quantitative PCR to discriminate
    Perret T; Kritikos A; Hauser PM; Guiver M; Coste AT; Jaton K; Lamoth F
    J Med Microbiol; 2020 May; 69(5):705-711. PubMed ID: 32369002
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical performance of BALF droplet digital PCR for differential diagnosis of Pneumocystis jirovecii pneumonia and Pneumocystis jirovecii colonization.
    Bian W; Shang Y; Zhao L; Wang K; Li R; Chen Y; Ma X; He Y; Yu W; Chen X; Liu C; Ni W; Gao Z
    Diagn Microbiol Infect Dis; 2024 Mar; 108(3):116168. PubMed ID: 38184984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study on the colonization of Pneumocystis jirovecii among outpatients during cancer chemotherapy and among healthy smokers.
    Takemoto S; Ebara M; Hasebe S; Yakushijin Y
    J Infect Chemother; 2017 Nov; 23(11):752-756. PubMed ID: 28843641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients.
    Botterel F; Cabaret O; Foulet F; Cordonnier C; Costa JM; Bretagne S
    J Clin Microbiol; 2012 Feb; 50(2):227-31. PubMed ID: 22162560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and clinical relevance of the quantitative touch-down major surface glycoprotein polymerase chain reaction in the diagnosis of Pneumocystis pneumonia.
    Chumpitazi BF; Flori P; Kern JB; Brenier-Pinchart MP; Hincky-Vitrat V; Brion JP; Thiebaut-Bertrand A; Minet C; Maubon D; Pelloux H
    Med Mycol; 2011 Oct; 49(7):704-13. PubMed ID: 21417683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of Pneumocystis jirovecii pneumonia and colonization in iatrogenically immunosuppressed and immunocompetent patients].
    Özkoç S; Bayram Delibaş S
    Mikrobiyol Bul; 2015 Apr; 49(2):221-30. PubMed ID: 26167822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens.
    Flori P; Bellete B; Durand F; Raberin H; Cazorla C; Hafid J; Lucht F; Sung RTM
    J Med Microbiol; 2004 Jul; 53(Pt 7):603-607. PubMed ID: 15184529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients.
    Mühlethaler K; Bögli-Stuber K; Wasmer S; von Garnier C; Dumont P; Rauch A; Mühlemann K; Garzoni C
    Eur Respir J; 2012 Apr; 39(4):971-8. PubMed ID: 21920890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study.
    Robert-Gangneux F; Belaz S; Revest M; Tattevin P; Jouneau S; Decaux O; Chevrier S; Le Tulzo Y; Gangneux JP
    J Clin Microbiol; 2014 Sep; 52(9):3370-6. PubMed ID: 25009050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.